The risk doesn’t
begin at launch.
Neither do we.
We partner with life sciences brand teams before the hard moments arrive – covering safety, adherence, and regulatory complexity from pre-registration through long-term commercial performance.
120+
Countries available
12+
Languages available
13+
Years of global delivery experience
High
The window between launch and success is where most therapies fail.*
The highest risk time for a brand’s commercial life is 24-36 months before launch. The time and momentum lost during this phase is rarely recovered. We’re your safety net.
We design commercialization infrastructure early, including patient engagement models, onboarding workflows, operational readiness planning, and safety-support architecture before launch pressure begins.
Helping you keep patients safe, HCPs supported, and your brand valued.
Based on Safety monitoring data, MS case study.
Not a vendor.A regulatory-grade infrastructure partner.
Brand teams don’t need another vendor to manage. They need a single partner who carries the complexity. RxPx offers three integrated capabilities, one system and no handoffs required, so your team stays focused on strategy, not firefighting.
Strategic consulting
We begin where strategy meets risk.
Before launch, before approval, before the risks are visible to anyone else – we assess, design, and build the commercialization infrastructure your therapy requires.
Features
- Launch readiness commercialization planning
- Patient journey design behavioral mapping
- HCP workflow prescription support tools
- Automated adverse event management
- Regulatory-grade audit trails compliance reporting
Patented technology
One intelligence layer across the therapy journey.
RxPx connects behavioral, adherence, clinical, and operational signals in one AI platform – surfacing patient risk, intervention needs, and safety escalations in real time.
Features
- Predictive adherence & engagement monitoring
- Real-time safety signal detection & escalation
- Closed-loop workflow orchestration
- Regulatory-grade audit visibility & compliance
End-to-end services
Where AI flags risk, humans close the gap.
Our clinical, operational, and patient engagement teams deliver the human navigator layer that turns intelligent signals into defensible action – every day, at global scale.
Features
- Patient onboarding therapy navigation
- 24/7 clinical nurse support triage
- HCP coordination prescriber support
- Benefits verification prior authorization
- Adverse event reporting safety oversight
- Launch readiness commercialization planning
- Patient journey design behavioral mapping
- HCP workflow prescription support tools
- Automated adverse event management
- Regulatory-grade audit trails compliance reporting
- Predictive adherence & engagement monitoring
- Real-time safety signal detection & escalation
- Closed-loop workflow orchestration
- Regulatory-grade audit visibility & compliance
- Patient onboarding therapy navigation
- 24/7 clinical nurse support triage
- HCP coordination prescriber support
- Benefits verification prior authorization
- Adverse event reporting safety oversight
“My nurse continues to be a great help and support to me through a difficult period of my life.”
“For every 3 minutes it takes to enroll a patient, it saves 3 hours!”
“This community has helped me so much! I love connecting with people who understand what I’m going through.”
Built for the therapies where failure isn’t an option.
We specialize in high-complexity therapies where the regulatory, safety, and adherence stakes are highest – and where the cost of a preventable failure is most severe.
Primary risks we manage across every therapy area.
Safety & clinical monitoring
Complex REMS and monitoring requirements
Real-time AE detection and reporting
Lifetime safety follow-up after dosing
Patient selection and protocol adherence
Post-treatment surveillance across lifecycle
Patient & access barriers
Toxicity-driven discontinuation and patient fear
Psychosocial barriers to adherence
Small populations and diagnosis delays
Complex diagnosis-to-treatment journeys
High cost and reimbursement barriers
Long-term follow-up & data integrity
Long-term persistence in isolated populations
Site readiness and coordination complexity
Regulatory-grade data in small cohorts
Data integrity for market authorization
Audit-ready documentation across decades of follow-up
Turn complex safety monitoring into a competitive advantage.
Specialty therapies with strict risk monitoring requirements often create operational complexity that providers avoid. Leading pharma teams are solving this with RxPx’s automated, coordinated, safety monitoring infrastructure.
Built for the regulatory needsof life sciences companies.
ISO 9001
ISO 13485
ISO 27001
GDPR
PIPEDA
HIPAA
What the best launchesdo differently.
We specialize in high-cost, high-complexity therapies where the regulatory, safety, and adherence stakes are highest – and where the cost of a preventable failure is most severe.
Why Most Therapies Fail After Approval (And No One Talks About It)
Every pharmaceutical launch is measured against ambitious commercial forecasts.
How Do We Embrace AI Without Compromising Ethics, Governance, and Trust?
How Do We Embrace AI Without Compromising Ethics, Governance, and Trust?
The Industry Shift Emerging From AXS26: From Fragmentation to Integration
At Asembia AXS26, one message surfaced repeatedly across conversations with manufacturers, specialty pharmacies, hubs, and patient support leaders: healthcare fragmentation is becoming impossible to ignore.
Don’t wait for risk to surface.Build defensible infrastructure now.
RxPx’s brand risk assessment reveals what your commercialization plan is missing
– and how to de-risk every phase before your first prescription.
*ZS Associates, “Why Your Best Science Is Losing and What Wins in Pharma Launches,” 2025. zs.com.